Nevro Corp. today raised the stakes on its forthcoming initial public offering, saying it will offer half a million more shares at a dollar over the high end of its prior range.
Wall Street Beat
Sientra nets $80m in IPO
Ebola fears could buoy Halyard Health’s public debut
Medtronic issues update on debt financing before Covidien merger | Medtech Wall Street news for the week of October 27, 2014
Sientra prices $75m IPO
Breast implant maker Sientra priced its initial public offering at $15 per share, saying it plans to issue 5 million shares for a total of $75 million.
Sientra, which also has designed implants for the buttocks, calf, pectoral region and face, has backers including Abingworth Bioventures, OrbiMed and Clarus Lifesciences.
Alere to sell Alere Health unit to Optum for $600m
Nevro sets range for IPO of up to $106m
Nevro Corp. set the price range for its forthcoming initial public offering, which would raise $106.3 million at the high end of the range.
Menlo Park, Calif.-based Nevro plans to trade on the NASDAQ exchange under the symbol NVRO, according to a regulatory filing.